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Acinetobacter baumannii is a Gram-negative nosocomial pathogen of importance due
to its uncanny ability to acquire resistance to most antimicrobials. These include
carbapenems, which are the drugs of choice for treating A. baumannii infections, and
polymyxins, the drugs of last resort. Whole genome sequencing was performed on
two clinical carbapenem-resistant A. baumannii AC29 and AC30 strains which had
an indistinguishable ApaI pulsotype but different susceptibilities to polymyxin. Both
genomes consisted of an approximately 3.8 Mbp circular chromosome each and several
plasmids. AC29 (susceptible to polymyxin) and AC30 (resistant to polymyxin) belonged
to the ST195 lineage and are phylogenetically clustered under the International Clone
II (IC-II) group. An AbaR4-type resistance island (RI) interrupted the comM gene in the
chromosomes of both strains and contained the blaOXA−23 carbapenemase gene and
determinants for tetracycline and streptomycin resistance. AC29 harbored another copy
of blaOXA−23 in a large (∼74 kb) conjugative plasmid, pAC29b, but this gene was absent
in a similar plasmid (pAC30c) found in AC30. A 7 kb Tn1548::armA RI which encodes
determinants for aminoglycoside and macrolide resistance, is chromosomally-located in
AC29 but found in a 16 kb plasmid in AC30, pAC30b. Analysis of known determinants
for polymyxin resistance in AC30 showed mutations in the pmrA gene encoding the
response regulator of the two-component pmrAB signal transduction system as well as
in the lpxD, lpxC, and lpsB genes that encode enzymes involved in the biosynthesis of
lipopolysaccharide (LPS). Experimental evidence indicated that impairment of LPS along
with overexpression of pmrAB may have contributed to the development of polymyxin
resistance in AC30. Cloning of a novel variant of the blaAmpC gene from AC29 and
AC30, and its subsequent expression in E. coli also indicated its likely function as an
extended-spectrum cephalosporinase.
Keywords: Acinetobacter baumannii, carbapenem-resistant, polymyxin, whole genome sequencing, resistance
island, resistance mechanisms
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INTRODUCTION
Acinetobacter baumannii is a significant nosocomial pathogen
that infects immunocompromised patients, including patients
with underlying diseases, especially those who are warded in
intensive care units (ICU; Bergogne-Bérézin and Towner, 1996;
Nordmann and Poirel, 2008; Camp and Tatum, 2010). These
nosocomial infections include ventilator-associated pneumonia,
secondary meningitis, endocarditis, urinary tract infections,
surgical site infections, and blood stream infections (Camp
and Tatum, 2010; Huang et al., 2012). A. baumannii is
intrinsically resistant to commonly used antibiotics such as
aminopenicillins, first- and second-generation cephalosporins
and chloramphenicol (Dijkshoorn et al., 2007). The notoriety
of this pathogen stems from its ability to develop and acquire
resistance to almost all antimicrobial drugs as well as its
tolerance to desiccation and ability to survive on inanimate
surfaces for prolonged periods of time (Camp and Tatum,
2010; Roca et al., 2012; Doi et al., 2015). In depth analyses of
the resistance mechanisms in A. baumannii revealed that its
multidrug resistance phenotype is mediated by all the major
resistance mechanisms that are known to occur in bacteria,
including modification of target sites, enzymatic inactivation,
active eﬄux, and decreased influx of drugs (Dijkshoorn et al.,
2007).
Carbapenem resistance in A. baumannii is usually acquired
with the most significant mechanism being the production of
carbapenemases (Poirel and Norman, 2006). A. baumannii
naturally produces the OXA-51-group carbapenemase at
a low level. The transposition of an insertion sequence
(usually ISAba1 or ISAba9) upstream of the blaOXA−51
gene provides a strong promoter for expression of the
carbapenemase leading to elevation of carbapenem MICs
and thus, resistance (Higgins et al., 2010). A. baumannii also
readily acquires several OXA-group β-lactamases usually
through transposons and plasmids with OXA-23 being
the most prevalent (Poirel and Norman, 2006; Roca et al.,
2012).
A. baumannii naturally produces the AmpC-type β-
lactamase and overexpression of the blaAmpC gene has
been associated with the presence of ISAba1 providing a
strong promoter leading to cephalosporin resistance (Segal
et al., 2005; Tian et al., 2011). These Acinetobacter-derived
cephalosporinases (ADCs) typically hydrolyze penicillins,
narrow- and extended-spectrum cephalosporins but not
cefepime or carbapenems (Rodríguez-Martínez et al., 2010).
Recently, several ADC variants have been identified that are
capable of hydrolyzing cefepime and these are termed as
extended-spectrum AmpCs (ESACs) (Rodríguez-Martínez et al.,
2010; Tian et al., 2011).
It is of great concern when carbapenems, which are the drugs
of choice for treatment, are increasingly compromised. As the
efficacy of these drugs decreases, polymyxins were re-introduced
as the drug of “last resort” (Landman et al., 2008). The renewed
interest in polymyxins (polymyxin B and colistin, or polymyxin
E) as therapeutic agents was due to the pathogen’s outer
membrane, polyanionic lipopolysaccharide (LPS) having high
affinity toward the cationic polymyxinmolecules (Landman et al.,
2008). Binding of the LPS and polymyxin molecules resulted in
a detergent-like effect that disrupts the outer membrane thereby
causing cytoplasm leakage of the pathogen (Landman et al., 2008;
Arroyo et al., 2011). Although polymyxins were once discarded
due to their neurotoxicity and nephrotoxicity, polymyxins
have a more effective antibacterial activity against most Gram
negative pathogens, including A. baumannii (Landman et al.,
2008). Previous studies from Garnacho-Montero et al. (2003)
and Moffatt et al. (2010) showed that intravenous polymyxins
were safe to use as an effective treatment to Acinetobacter
infections. However, uncontrolled use or overuse of polymyxins
in the hospital environment may lead to the development
of polymyxin-resistance in A. baumannii (Arroyo et al.,
2011).
Polymyxin resistance in A. baumannii appeared to develop
intrinsically as a result of exposure to this class of drugs.
Two major mechanisms of polymyxin resistance have been
described for A. baumannii. The first is the modification of
the lipid A moiety of LPS with phosphoethanolamine as a
result of mutations in the pmrA/pmrB two-component signal
transduction system which leads to the up-regulated expression
of the pmrCAB operon. Overexpression of pmrC which
encodes the enzyme responsible for phosphoethanolamine
addition to lipid A, impairs the binding of polymyxin
to the outer membrane thereby leading to resistance
(Adams et al., 2009; Arroyo et al., 2011; Beceiro et al.,
2011; Park et al., 2011). The second mechanism is the
complete loss of the LPS caused either by mutations or the
insertional inactivation of the lipid A biosynthesis genes,
namely lpxA, lpxC, and lpxD (Moffatt et al., 2010, 2011).
Mutations in the lpsB gene that encodes a glycosyltransferase
involved in the biosynthesis of the LPS core have also
been implicated in polymyxin resistance (Hood et al.,
2013).
We have previously characterized 54 A. baumannii strains
obtained from a tertiary hospital in Terengganu, Malaysia (Lean
et al., 2014). Out of these, 39 were carbapenem- and multidrug-
resistant (MDR). Among the 39 carbapenem resistant strains, 14
were also resistant to polymyxin B and categorized as extensive-
drug resistant (XDR). Two strains, A. baumannii AC29 and
AC30 were isolated from the wounds of different patients, and
shared an identicalApaI pulsotype. However, AC29 is susceptible
to polymyxin B whereas AC30 was resistant with an MIC
value of 128µg/ml. Here, we report the comparative genomic
analyses of these two A. baumannii strains, AC29 and AC30,
to show that despite sharing an identical pulsotype, there are
significant changes in the genome structure particularly in the
resistance islands and the plasmid content of the two isolates.
We also present experimental evidence to elucidate possible
mechanisms for the development of polymyxin resistance in
A. baumannii AC30 and the likely implication of a novel
blaAmpC cephalosporinase gene in resistance to extended-
spectrum cephalosporins as well as imipenem in both AC29 and
AC30.
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MATERIALS AND METHODS
Whole Genome Sequencing
Strains Selection, Antibiotic Resistance Profiles, and
DNA Extraction
Two strains of A. baumannii AC29 and AC30 from a tertiary
hospital in Terengganu, Malaysia were selected for this study
(Lean et al., 2014). Both strains were obtained from the wounds
of different patients using standard microbiology procedures. A.
baumannii AC29 and AC30 shared an identical ApaI pulsotype
and showed resistance to gentamycin, tobramycin, amikacin,
ciprofloxacin, levofloxacin, piperacillin-tazobactam, cefotaxime,
ceftazidime, cefepime, ampicillin-sulbactam, tetracycline, and
doxycycline. Both isolates were also resistant to carbapenem with
MIC values of >32µg/ml for both imipenem and meropenem
(Clinical and Laboratory Standards Institute, 2013). However,
AC29was susceptible to polymyxin Bwhereas AC30was resistant
with an MIC value of 128µg/ml (Magiorakos et al., 2011; Lean
et al., 2014).
Genomic DNA of AC29 and AC30 were extracted using
Wizard Genomic DNA Purification Kit (Promega, USA)
according to the manufacturer’s instructions. Extracted DNAwas
quantified using the spectrophotometer at OD260 and the purity
was determined by OD260/OD280 ratio (Ausubel et al., 2002).
Genomic Sequencing, Assembly, and
Annotations
Whole genome sequencing of A. baumanniiAC29 and AC30 was
carried out by a commercial vendor using the Illumina Genome
Analyzer IIx platform. CLC Bio software package was used to
assemble the genome sequence data. Open reading frame (ORF)
prediction and gene functional assignments were done using
Prodigal 2.60 (Hyatt et al., 2010), RNAmmer 1.2 (Lagesen et al.,
2007), and tRNAscan-SE (Lowe and Eddy, 1997). Functional
annotation of the genome was performed using Blast2Go and the
Rapid Annotation using Subsystem Technology (RAST) server
(Aziz et al., 2008).
MLST and Phylogenetic Analysis
To determine the sequence types, multilocus sequence typing
(MLST) of AC29 and AC30 was performed according to the
Bartual or Oxford scheme using the seven housekeeping genes
cpn60, gdhB, gltA, gpi, gyrB, recA, and rpoD (Bartual et al.,
2005) and the Pasteur scheme using the genes cpn60, fusA,
gltA, pyrG, recA, rplB, and rpoB (Diancourt et al., 2010). The
gene sequences were compared to the PubMLST database for A.
baumannii (http://pubmlst.org/abaumannii/) and assigned to the
appropriate sequence types.
The phylogenetic relationship of AC29 and AC30 to
sequenced A. baumannii strains was inferred using composition
vector tree (CVTree) version 2 (Xu and Hao, 2009) based on
the concatenated nucleotide sequences of the seven reference
genes used in the Bartual MLST scheme. The CVTree web-based
server (http://tlife.fudan.edu.cn/cvtree/) generates phylogenetic
trees based on k-tuple values (Xu and Hao, 2009). The completed
A. baumannii genomes used in the analysis were downloaded via
the NCBI FTP site and the reference gene sequences extracted for
phylogenetic analysis.
Comparative Genomics Analyses
Whole genome sequences of these two A. baumannii AC29
and AC30 strains were compared to our previously reported A.
baumannii AC12 genome (Lean et al., 2015) and the completed
A. baumannii genomes available from NCBI FTP site using
Mauve (Darling et al., 2004). Circular chromosome and plasmid
map of these strains were constructed using CGView Server
developed by the Stothart Research Group (Grant and Stothard,
2008).
Accession Numbers
Genome sequences ofA. baumannii strains AC29 and AC30 were
deposited under the accession number CP007535 and CP007577,
respectively. Plasmid sequences of pAC29a, pAC29b, pAC30a,
pAC30b, and pAC30c were deposited under the accession
number CP008850, CP008851, CP007578, CP007579, and
CP007580, respectively. Accession numbers for our previously
reported A. baumannii strain AC12 (CP007549) and pAC12
(CP007550) were as in (Lean et al., 2015).
Quantitative Real-Time PCR Of pmrAB
One of the gene loci that have been implicated in polymyxin
resistance is the pmrCAB operon with pmrAB encoding the two-
component signal transduction system and pmrC encoding the
enzyme that catalyzes the addition of phosphoethanolamine to
the lipid Amoiety of lipopolysaccharide (LPS; Arroyo et al., 2011;
Park et al., 2011; Hood et al., 2013). To determine the transcript
levels of pmrAB from the polymyxin-susceptible AC29, and the
polymyxin-resistant isolates AC30 as well as AC12 (Lean et al.,
2015), quantitative real-time PCR (qRT-PCR) was employed. A.
baumannii ATCC19606 was used as the polymyxin-susceptible
control. Total RNA was extracted from A. baumannii strains
grown in LB broth using Qiagen RNeasy Mini Kit (Qiagen).
The extracted total RNAwas subjected to reverse transcription
using the Quantitect Reverse Transcription Kit (Qiagen) in a T-
Gradient PCR machine from Biometra/Applied Biosystems. The
resulting cDNA produced was used as template for quantitative
real-time PCR using the SYBR Green PCR Kit (Qiagen)
performed in a Rotor-Gene 6000 Real-Time PCR Machine
(Corbett Life Science/Qiagen). Prior to the actual amplification
cycling conditions, the mixture was subjected to initial heat
activation at 95◦C for 5min followed by 35 cycles of the two-step
cycling condition of denaturation at 95◦C for 10 s and annealing
at 60◦C for 30 s. The melting curve profile for each amplification
reaction and the relevant CT value were automatically generated
using the software provided (Corbett Life Science/Qiagen). The
rpoB gene was used as the housekeeping gene for normalization
(Park et al., 2011). Relative quantification using the 11CT
method (Pfaﬄ, 2001) was then applied to quantify the expression
of pmrAB.
Lipopolysaccharide Analysis
Lipopolysaccharide (LPS) analysis was carried out for the
polymyxin resistant strains AC30 and AC12 (Lean et al.,
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2015), the polymyxin susceptible strain AC29 along with A.
baumannii ATCC19606 as the polymyxin-susceptible control.
LPS extraction was carried out according to Hood et al.
(2013). Briefly, bacteria were swabbed from LB agar plates
into 154mM NaCl, and the cell density was adjusted to an
OD600 of 1.5, pelleted and resuspended in lysis buffer (2% SDS,
4% 2-mercaptoethanol, 10% glycerol, 0.1M Tris-HCl, pH 6.8).
Samples were then boiled for 10min, cooled to 60◦C and treated
with proteinase K for 1 h. These samples were electrophoresed
through a 15% polyacrylamide gel using standard methods
and stained with Pro-Q Emerald 300 LPS stain according to
the manufacturer’s recommendations (Invitrogen). Molecular
weight marker used in the experiment was the Precision Plus
Protein Dual Xtra Standards (BioRad). The stainedminigels were
then viewed and photographed under UV light using a UV Gel
Imager (Alpha-Innotech).
Cloning and Expression of the Novel Variant blaAmpC
Gene
The novel variant blaAmpC gene was PCR-amplified from the
genomes of A. baumannii AC29 and AC30 using specific primers
ampC_BamHI: 5′-GGATCCATGGCTGTGGGTGTTATTCAA-
3′ and ampC_HindIII: 5′-AAGCTTTTATTTCTTTATTGCATT
CAGCAC-3′ with the following conditions—initial hold at 95◦C
for 3min, followed by 40 cycles of 95◦C for 50 s, 55◦C for 50 s,
72◦C for 1min, and final extension at 72◦C for 90 s. Purified PCR
products were then cloned into pGEM-T Easy (Promega, USA)
according to the manufacturer’s instructions and transformed
into E. coli JM109. Transformants were selected on LB agar
supplemented with 100mM ampicillin with 100mM IPTG and
50mg/ml X-gal. Plasmids were prepared from white colonies
and screened by digestion with BamHI and HindIII which cut
at the restriction sites incorporated into the primers used for
amplification. Plasmids with the expected restriction fragments
were validated by conventional Sanger dideoxy sequencing prior
to subcloning into the pET30a expression vector. The resulting
pET30a-ampC recombinant plasmids were then transformed
into E. coli BL21 (DE3/pLysS) and expression of the cloned
blaAmpC gene carried out by inducing the cells with 0.1mM
IPTG. After that, the E. coli BL21 recombinant clones were tested
for their MIC values for extended-spectrum cephalosporins (i.e.,
ceftazidime and cefepime) as well as aztreonam and imipenem at
concentrations of 2, 4, 8, 16, and 32µg/ml using the agar dilution
method.
RESULTS
Strain Characteristics and Genome
Analyses
Basic Genome Features and Sequence Types
Analyses of the whole genome sequencing indicated that the
A. baumannii AC29 and AC30 genomes were 3,935,134 and
3,925,274 bp, with GC content of 38.84 and 38.98%, respectively.
Predicted ORFs from the genomes of A. baumannii AC29 and
AC30 were 3728 and 3646, respectively. Both strains contained
only one chromosome with varying number of plasmids, as
TABLE 1 | General genomic features of the whole genome sequences of
A. baumannii strains AC29 and AC30.
Feature Strains
AC29 AC30
Accumulated length 3,935,134 bp 3,925,274 bp
Average GC content 38.84% 38.98%
Number of contigs 102 91
Number of ORF 3728 3646
Number of tRNA 66 58
Number of rRNA 4 3
Number of plasmid 2 3
Plasmid size pAC29a (8737 bp)
pAC29b (74,749 bp)
pAC30a (8729 bp)
pAC30b (16,236 bp)
pAC30c (71,433 bp)
featured in Table 1. The Bartual or Oxford scheme for MLST
utilizes seven housekeeping genes cpn60, gdhB, gltA, gpi, gyrB,
recA, and rpoD to determine the sequence type (ST) of A.
baumannii (Bartual et al., 2005). Both AC29 and AC30 were
designated ST195 (derived from cpn60-2, gdhB-3, gltA-1, gpi-96,
gyrB-3, recA-2, and rpoD-3) whereas using the Pasteur MLST
scheme (Diancourt et al., 2010), both A. baumannii strains were
designated ST2 (cpn60-2, fusA-2, gltA-2, pyrG-2, recA-2, rplB-
2, and rpoB-2). Thus, AC29 and AC30 were categorized as
belonging to the International Clone-II (or IC-II, also referred
to as Global Clonal 2, or GC2) group of strains.
Phylogenetic analysis of the A. baumannii AC29 and AC30
genomes were performed with other available A. baumannii
genomes from the NCBI’s FTP site and using A. baumannii
SDF as an outgroup to root the phylogenetic tree based on
the concatenated nucleotide sequences of the seven reference
genes utilized in the Bartual MLST scheme (Farrugia et al.,
2013). Based on the phylogenetic tree (Figure 1), A. baumannii
AC29 and AC30 were closely related to A. baumannii AC12
which was also isolated from the same hospital in Terengganu
and was also typed as ST195 (Lean et al., 2015) along with A.
baumanniiM1 which was also isolated from Malaysia (accession
no. LAIL0100000). These strains were clustered together with
other A. baumannii isolates of the IC-II group and this was
also reflected in their genome grouping based on genomic
BLAST (as indicated at http://www.ncbi.nlm.nih.gov/genome/
genomegroups/403? accessed on 19 August 2015).
The AbaR4-Type Resistance Island
The genomes of A. baumannii AC29 and AC30 contained an
AbaR4-type resistance island (RI) which interrupts the comM
gene (Nigro and Hall, 2012). The island found in AC29 is
23 kb and designated AC29-RI1 whereas in AC30, it is 26 kb
and designated AC30-RI1. Tn6022 and/or 1Tn6022 is part of
the important features for this type of RI; in AC29-RI1, only
the entire tniC gene is deleted in 1Tn6022 whereas AC30-RI1
carries a complete copy of Tn6022 (Figure 2). In AC29-RI1,
the 1Tn6022 is missing the tniC gene on its far left end, but
full-length tniD and tniE genes are present in the transposon.
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FIGURE 1 | Phylogenetic analysis of A. baumannii AC12, AC29, AC30, and completed A. baumannii genomes obtained from NCBI. The phylogenetic tree
was constructed by composition vector tree version 2 (CVTree 2) using concatenated nucleotide sequences of the seven reference genes based on the
Bartual/Oxford MLST scheme (cpn60, gdhB, gltA, gpi, gyrB, recA, and rpoD). Strains belonging to the international clonal groups IC-I, IC-II, and IC-III are indicated.
The accession nos. of the strains used in the analysis are as follows: AB307-0294 (CP001172.1), AYE (CU459141.1), AB0057 (CP001182.1), ACICU (CP000863.1),
1656-2 (CP001921.1), TCDC-AB0715 (CP002522.2), BJAB0868 (CP003849.1), BJAB07104 (CP003846.1), M1 (LAIL01000001.1), TYTH-1 (CP003856.1), MDR-TJ
(CP003500.1), MDR-ZJ (CP001937.1), OIFC137 (NZ_AFDK01000002.1), SDF (NC_010400.1).
AC30-RI1 contains the full length Tn6022. In both AC29-RI1 and
AC30-RI1 islands, only one copy of either1Tn6022 or Tn6022 is
found.
Drug resistance genes found in the AC29-RI1 and ACRI30-1
islands are sulI (conferring sulphonamide resistance), blaOXA−23
(conferring carbapenem resistance), tetA and tetB (conferring
tetracycline resistance), and strA with strB (conferring
streptomycin resistance). The blaOXA−23 gene is flanked by
two copies of the ISAba1 insertion element in a composite
transposon structure similar to Tn2006 (Figure 2). Tn2006
comprises of the blaOXA−23 carbapenemase-encoding gene, a
DEAD/DEAH box helicase-like gene and an ATPase gene (yeeA)
flanked by two copies of ISAba1.
Plasmids of A. baumannii AC29 and AC30
A Small 8.7 kb Plasmid Found in Both AC29 and AC30
Sequence analysis revealed the presence of a small 8.7 kb
plasmid in both the genomes of A. baumannii AC29 and AC30,
designated pAC29a and pAC30a, respectively (Table 1). These
plasmids contained a total of nine coding sequences (CDS)
(Figure 3). No antibiotic resistance gene was found on these
plasmids. Two plasmid replication genes, designated repA and
repB, were found on these plasmids along with an iteron sequence
made up of four direct repeats of 5′-ATA TGT CCA CGT TTA
CCT TGC A-3′ located 53 nucleotides upstream of the repB
gene. Other features on this cryptic plasmid are a Sel1 repeat
protein-encoding gene (sel1) which is flanked by XerC/XerD-like
recombination sites in an inverted repeat formation, an outer
membrane TonB-dependent receptor gene, a gene encoding
for putative septicolysin and two hypothetical protein-encoding
genes. A toxin-antitoxin (TA) system designated AbkB/AbkA
(Mosqueda et al., 2014) was also encoded on these 8.7 kb
plasmids.
pAC30b, a 16.2 kb Resistance Plasmid Found in
A. baumannii AC30
Plasmid pAC30b is 16,236 bp in size and is found only in A.
baumannii AC30. pAC30b contained 11 CDS and is a resistance
plasmid, as indicated by the presence of the 16S rRNA methylase
gene (armA) and aminoglycoside 3′-phosphotransferase gene
(aphA1) which confer resistance to aminoglycosides, along with
macrolide 2′-phosphotransferase (mph2) and macrolide eﬄux
protein-coding (mel) genes which confer resistance to macrolides
(Figure 4; Zhou et al., 2011). The armA, mph2, and mel genes
along with adjacent putative transposase genes tnpD and tnpU
make up a small 7 kb RI designated Tn1548::armA which have
been reported in several other plasmids from Enterobacteriaceae
(Dolejska et al., 2013).
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FIGURE 2 | Structures of resistance islands present in A. baumannii AC12, AC30, and AC29 as compared to similar islands in A. baumannii MDR-ZJ
and MDR-TJ. (A) Structure of resistance island ACRI12-1 present in A. baumannii AC12. 1Tn6022, Tn6022, and Tn2006 are indicated in the red dotted-line box.
Directions of genes and ORFs are indicated by arrows above the central thick line and the names are as given above. Green boxes represent truncated 1comM,
turquoise blue boxes represent insertion element, ISAba1, and orange boxes represent genes conferring antibiotic resistance. Numbered boxes in gray represent
genes encoding for hypothetical proteins. Comparison between structures of (A) AC12-RI1, (B) AC30-RI1, (C) AC29-RI1, (D) AbaR22, and (E) RIMDR−TJ, revealed
similarities in the islands, as indicated by the same colors and red dotted-line box.
The tnpU putative transposase gene located at the 3′-end of
Tn1548::armA is truncated in pAC30b whereby only the last 480
bp of the 836-bp gene could be found and was thus designated
∆tnpU. The pAC30b plasmid encodes a number of putative
transposases: ∆tnpU and tnpD from Tn1548::armA, tnpA, and
tnpB transposases from IS66, a 2888-bp tnpA from the Tn3 family
of transposases (or Tn1000-like) and immediately adjacent to
that, another smaller 704-bp tnpA transposase belonging to IS26.
The aminoglycoside resistance gene aphA1 is found downstream
from IS26.
A Large ca. 70 kb Conjugative Plasmid in the
Genomes of A. baumannii AC29 and AC30
Both A. baumannii AC29 and AC30 were found to harbor
similar conjugative plasmids of ca. 70 kb in size designated
pAC29b and pAC30c, respectively. There are a total of 101
CDS in the 74,749 bp pAC29b whereas pAC30b is 71,433 bp
and contains a total of 96 CDS. Both pAC29b and pAC30c
encode a complete tra locus (Figure 5) similar to the tra locus
found in pACICU2 (Iacono et al., 2008), p2ABTCDC0715
(Chen et al., 2011), pAb-G7-2 (Hamidian and Hall, 2014),
and pA85-3 (Hamidian et al., 2014). Genes for the T4SS in
pAC30c and pAC29b are clustered in two separate regions: the
main tra region responsible for mating pair formation spans
approximately 20 kb from traL to traG, and a second smaller
region containing traD and traI (or trwB and trwC) responsible
for plasmid mobilization. In pAC30c, the space between these
two regions contains several hypothetical ORFs and a solitary
relE toxin gene without the corresponding relB antitoxin gene
(Figure 5).
Plasmid pAC29b is larger by 3316 bp when compared
to pAC30c. However, there is a 14,374 bp fragment in
pAC30c which has no homology with pAC29b. The additional
fragment found in pAC29b included the β-lactamase gene
blaOXA−23 and two transcriptional regulators, tetR and asnC.
Other identifiable genes within this pAC29b-unique fragment
include yeeA (encoding DNAmethyltransferase), yeeB (encoding
ATP-dependent helicase), yhbS (encoding N-acetyltransfease),
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FIGURE 3 | Linear map showing the genetic organization of plasmids pAC29a, pAC30a, and pAC12 in comparison with other similar A. baumanii
plasmids. The XerC/XerD-like recombination sites are indicated in black rectangular boxes with the nucleotide sequences as indicated above the boxes. The two
plasmid replication genes, repB and repA, are indicated in blue whereas the putative abkA/abkB toxin-antitoxin genes are indicated in green arrows. Hypothetical
ORFs are shaded gray. The TonB-dependent receptor gene is indicated in yellow whereas the putative septicolysin gene is in orange.
FIGURE 4 | Linear map comparison of the Tn1548::armA region in plasmid pAC30b from A. baumannii AC30 and pMDR-ZJ06 from A. baumannii
MDR-ZJ06 (NC_017172). The Tn1548::armA region and insertion elements (IS) were underlined and indicated in the diagram.
mscM (encoding mini-conductance mechanosensitive channel),
iutA (encoding ferric aerobactin receptor), lrp (encoding
leucine-responsive regulatory protein), and aroQ (encoding
monofunctional chorismate mutase). Thus, AC29 harbors two
copies of blaOXA−23—one within the AbaR4-like AC29RI-1
island in the chromosome, and another encoded on the pAC29b
plasmid. However, plasmid pAC30c does not encode for any
known resistance determinant.
Investigations into the Possible
Contributors of Polymyxin Resistance in
A. baumannii AC30
To investigate if differential expression of pmrAB occurred
in the polymyxin-resistant AC30 as well as AC12 strains,
relative quantification of the pmrAB transcript levels were
determined by qRT-PCR with A. baumannii ATCC19606 as the
polymyxin-susceptible control. When compared to ATCC19606,
the relative expression levels of pmrA in AC30 was surprisingly
lower at about 0.2-folds but levels of pmrB were higher at
4.8-folds (Figure 6). In contrast, the other polymyxin-resistant
strain, AC12 displayed about 8.5-folds higher pmrA expression
levels and about two-folds higher pmrB levels in comparison
with ATCC19606. The polymyxin-susceptible AC29 showed
dramatically lower pmrAB expression, at about 0.05- and 0.03-
folds, respectively.
LPS from the two polymyxin-resistant strains, AC12 and
AC30, along with two polymxyin-susceptible strains AC29
and ATCC19606 were extracted and analyzed on 15% SDS-
polyacrylamide gels (Figure 7). SDS-PAGE of the extracted LPS
yielded a band of ∼10 kD, which was within the expected
molecular weight (between 6 and 10 kDa) for LPS. Results
indicated that the LPS in the polymyxin resistant strains AC12
and AC30 were not totally absent as had been previously reported
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FIGURE 5 | Circular map of the ∼70kb plasmids pAC30c (A) and pAC29b (B). Outer circle of the map represents ORFs found in the plasmid, gray ORFs are
genes encoding for hypothetical proteins. The two inner circles represent GC plot and GC skew, whereby the green circle stands for above average and black circle
stands for below average G+C content. Red colored arrow represents plasmid replication gene, rep; orange colored arrow represents resistant determinants; pink
colored arrow represents tra genes; black colored arrow represents genes encoding proteins with known functional homologs; purple colored arrow represents
putative toxin gene homologs of toxin-antitoxin systems; and gray colored arrow represents genes encoding hypothetical proteins.
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FIGURE 6 | Relative expression levels of pmrAB of the polymyxin-resistant A. baumannii AC12 and AC30 as compared to the polymyxin-susceptible
A. baumannii AC29 as determined by Quantitative Real-Time reverse transcriptase-PCR (qRT-PCR). The data represents the mean fold change ± standard
deviation (SD; indicated as error bars in the graph) taken from three replicates performed for each qRT-PCR reaction. Asterisk (*) indicate statistical significance, as
determined by using two-tailed, unpaired Student’s t-test with p < 0.05.
FIGURE 7 | SDS-PAGE analysis of the extracted lipopolysaccharide
(LPS) layer of the A. baumannii ATCC19606 (control; polymyxin
susceptible strain), AC12 (polymyxin resistant strain), AC29 (polymyxin
susceptible strain), and AC30 (polymyxin resistant strain). M stands for
the protein marker Precision Plus Protein Dual Xtra Standards (BioRad) with
the sizes as indicated in kDa.
in other polymyxin-resistant strains (Moffatt et al., 2010, 2011;
Hood et al., 2013) but the intensity of the LPS band was
considerably less when compared with the LPS band of the
polymyxin-susceptible strains.
AmpC-Mediated Resistance to
Extended-Spectrum Cephalosporins
The AmpC cephalosporinase encoded by A. baumannii AC29
and AC30 displayed identical non-synonymous mutations,
TABLE 2 | MIC values of the ampC clones in IPTG-induced E. coli BL21
toward selected antibiotics.
Clones MIC value (µg/mL)
Aztreonam Ceftazidime Imipenem Cefepime
BL21_ampC-AC12 16 16 32 16
BL21_ampC-AC30 16 16 32 16
BL21_ampC-AC29 16 16 32 16
Control (BL21_pET30a) 2 2 2 2
R80S and G246S (with reference to ADC-7, the reference
A. baumannii-encoded AmpC; Hujer et al., 2005; Rodríguez-
Martínez et al., 2010) to that found in A. baumannii AC12 (Lean
et al., 2015) but the effects of these mutations on cephalosporin
resistance have not been reported. To investigate if the mutations
in the blaAmpC gene harbored by A. baumannii AC29 and
AC30 has any effect on resistance against β-lactams especially
cephalosporins, these genes were cloned and expressed in E. coli
BL21 through the IPTG-inducible T7 promoter of the pET30a
vector. Recombinant E. coli BL21 carrying the blaAmpC from
AC29 and AC30 displayed resistance to ceftazidime, cefepime,
aztreonam, and even imipenem (Table 2). Thus, the blaAmpC
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encoded by AC29 and AC30 is likely an extended-spectrum
Acinetobacter-derived AmpC (ESAC).
Other Resistance Determinants and Efflux
Pumps
Besides the blaAmpC-encoded cephalosporinase (belonging to
Ambler Class C β-lactamases) and the Class D carbapenemases
encoded by blaOXA−23 and blaOXA−51 that were described in the
previous sections, two other β-lactamase genes were found in
the genomes of AC29 and AC30 (Table 3). These are the blaTEM
gene which encodes class A extended-spectrum β-lactamase and
a gene identified as belonging to the metalo-β-lactamase family
(Ambler Class B). The contributions of these genes to the β-
lactam resistance phenotype of AC12 and AC30 are currently
unknown.
One of the main mechanisms of fluoroquinolone resistance
is mutations that alter the drug targets. The targets of
fluoroquinolone action are the bacterial enzymes DNA gyrase
(encoded by gyrA and gyrB) and DNA topoisomerase IV
(encoded by parC and parE), both of which work together
in replication, transcription, recombination and repair of
DNA (Jacoby, 2009).The AC29 and AC30-encoded gyrA and
parC showed the Ser → Leu amino acid substitutions at
positions 83 and 80, respectively, which have been implicated in
fluoroquinolone resistance (Wisplinghoff et al., 2003; Fournier
TABLE 3 | Genes conferring antibiotic resistance found in A. baumannii AC29 and AC30.
Antibiotics Genes Contig location Products
AC29 AC30
Aminoglycosides aadA 3_40 10_40 Adenyltransferase
aadA1a 3_40 10_40 Aminoglycoside adenylyltransferase
aphA1b 88_1 91_1 Aminoglycoside 3′-phosphotransferase
strA 54_7 38_7 Phosphotransferase
strB 54_6 38_6 Phosphotransferase
Beta-lactams ampC 14_1 37_1 Beta-lactamase Class C
blaTEM 85_1 87_1 Beta-lactamase TEM
Class A beta-lactamase 34_58 6_58 Beta-lactamase Class A
MBL 16_33 3_184 Metallo-beta-lactamase family protein
blaOXA−23 60_16 40_16 Beta-lactamase OXA-23
blaOXA−51 53_6 60_1 Beta-lactamase OXA-51
Carbapenems carO 16_123 6_123 Putative porin protein associated with imipenem resistance
Chloramphenicol cmlA 35_12 47_5 Major facilitator superfamily permease
cmlA 35_12 47_5 cmlA transporter
Fluoroquinolones parC 45_19 49_19 DNA topoisomerase IV subunit A
parE 17_100 1_100 DNA topoisomerase IV subunit B
gyrA 16_68 3_149 DNA gyrase subunit A
gyrB 40_38 23_38 DNA gyrase subunit B
Tetracyclines tetA, Class A 54_1 38_1 Tetracycline resistance protein
tetR 54_2 38_2 Tetracycline repressor protein
Trimethoprim dhfrI 33_27 5_27 Dihydrofolate reductase
Sulfonamides sulI 16_16 57_14 Dihydropteroate synthase
Polymyxin B pmrA 15_53 34_55 Polymyxin resistance component, PmrA
pmrB 15_54 34_54 Polymyxin resistance component, PmrB
pmrC 15_55 43_1/39_1 Polymyxin resistance component, PmrC
Colistin lpxA 29_1 13_136 UDP-N-acetylglucosamine acyltransferase
lpxB 38_1 8_113 Lipid-A-disaccharide synthase
lpxC 12_51 1_129 UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase
lpxD 19_75 13_138 UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase
lpxH 17_129 35_87 UDP-2,3-diacylglucosamine hydrolase
lpxK 12_53 8_19 Tetraacyldisaccharide 4′-kinase
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et al., 2006; Maragakis and Perl, 2008). However, four additional
novel point mutations (G145D, S118G, L644P, and T872A)
were observed in the AC29 and AC30-encoded gyrA. Whether
these mutations contribute to fluoroquinolone resistance in A.
baumanniiAC29 and AC30 would require further investigations.
Multidrug eﬄux pumps and porins also play important
roles in A. baumannii antimicrobial resistance (Vila et al.,
2007). Among the five major families of bacterial eﬄux pumps
(i.e., RND, MFS, APC, ABC, and MATE; Table 4), the RND
family is widely disseminated in Gram-negative bacteria (Poole,
2004; Bonomo and Szabo, 2006; Nordmann and Poirel, 2008;
Wieczorek et al., 2008). The genome analysis of A. baumannii
AC29 and AC30 showed the presence of the complete adeABC
genes along with its two-component regulatory genes, adeRS.
Another member of the RND family encoded by adeIJK was
also present in AC29 and AC30. However, a third RND eﬄux
pump encoded by the adeFGH operon was absent in both
isolates. Overexpression of adeABC and to a certain extent,
adeIJK, has also been associated with the multidrug resistance
phenotype in A. baumannii (Vila et al., 2007) and it would be
of interest to investigate if this is likewise in A. baumannii AC29
and AC30.
TABLE 4 | Drug transporter and efflux pumps found in A. baumannii AC29 and AC30.
Drug transporters Genes Contig location Gene products
AC29 AC30
APC family transporter cycA 16_60 3_157 D-serine/D-alanine/glycine transporter
cycA2 3_70 10_70 amino acid APC transporter
3_71 10_71 amino acid APC transporter
mmuP 67_1 22_32 S-methylmethionine APC transporter
proY 17_59 1_59 proline-specific permease ProY
RND family transporter adeA 31_11 16_59 membrane-fusion protein
adeB 31_10 16_60 cation/multidrug efflux pump
adeC 31_9 16_61 multidrug efflux protein AdeC
adeI 15_38 34_39 multidrug efflux protein AdeI
adeJ 15_39 34_40 multidrug efflux protein AdeJ
adeK 15_40 34_41 multidrug efflux protein AdeK
adeR 31_21 16_58 AdeR
adeS 31_13 16_57 AdeS
fusE 9_83 19_57 Putative FusE-MFP/HlyD membrane fusion protein
mdtA 20_59 14_55 multidrug ABC transporter
nolF 35_29 4_13 NolF secretion protein
RND efflux pumps 35_29 4_13 NolF secretion protein
MFS family transporter emrB 26_33 27_212 major facilitator superfamily multidrug resistance protein
fsr 25_59 27_36 major facilitator superfamily permease
bcr 35_12 47_5 MFS superfamily bicyclomycin/multidrug transport protein
MFS superfamily protein 12_101 13_186 transporter, major facilitator family protein
MFS transporter 19_98 8_90 major facilitator superfamily permease
ygaY 8_35 18_33 transporter, major facilitator family protein
norM 9_13 19_5 multidrug ABC transporter
cmr 22_155 22_42 major facilitator superfamily multidrug/chloramphenicol efflux transporter
ABC family transporter ABC efflux pump 9_13 19_5 multidrug ABC transporter
Na+ driven transporters Na+ driven efflux pump 17_88 1_88 Na+-driven multidrug efflux pump
Efflux pumps abeM 9_13 19_5 multidrug efflux pump AbeM
dmt 16_81 3_136 EamA-like transporter family protein
ywfM 56_27 12_128 DMT family permease
MATE efflux pump 17_88 1_88 MATE efflux family protein
SMR smr 22_155 14_62 multidrug resistance protein, SMR family
20_66 14_1 Smr protein/MutS2
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DISCUSSIONS
Whole Genome Sequencing and Sequence
Types
In this study, we applied comparative genomics on two A.
baumannii strains that are indistinguishable by PFGE but have
different antibiograms to better understand their mechanism
of resistance. Although these two strains only differed by
their susceptibility toward polymyxin B (AC29 was susceptible
whereas AC30 was resistant), detailed genomic analysis indicated
a number of differences in the RI structures and the plasmid
contents. Both A. baumannii AC29 and AC30 were typed
as ST195 and, not surprisingly, their closest neighbor was
A. baumannii AC12 which was also another ST195 strain as
previously reported from (Lean et al., 2015). Another close
neighbor wasA. baumanniiM1, an isolate fromMalaysia that was
recently deposited and from its genome sequence, was deduced to
be also ST195. All these strains were clearly clustered in the IC-II
group of global A. baumannii clones (Figure 1). Strains that were
typed as ST195 under the Bartual MLST scheme are grouped into
the clonal complex 92 (CC92) which are characterized as under
IC-II (Kim et al., 2013; Zarrilli et al., 2013).
The AbaR4-Type Resistance Island
One of the known hotspots for the insertion of resistance islands
in A. baumannii is the comM gene (Post et al., 2010; Zhou et al.,
2011; Huang et al., 2012; Kim et al., 2013). The genomes of A.
baumanniiAC29 and AC30 also contained a similar island within
comM but with slight differences. Previous analysis of the A.
baumanniiAC12 genome showed the presence of a 23 kb AbaR4-
type island designated AC12-RI1 within comM (Lean et al., 2015)
which consisted of a backbone of Tn6167 and a truncated version
of Tn6022 designated1Tn6022. In all three islands (i.e., AC12RI-
1, AC29RI-1, and AC30RI-1), only one copy of either 1Tn6022
or Tn6022 is found whereas other similar resistance islands
usually contained two copies of 1Tn6022 and/or Tn6022. For
instance, in RIMDR−TJ and AbaR22, another copy of the complete
Tn6022 was located next to the tetA(B) gene (Figure 2). Besides
that, the blaOXA−23 gene in AC12-RI1, AC29-RI1, and AC30-
RI1 was found flanked by two copies of the ISAba1 insertion
element in a composite transposon structure similar to Tn2006
(Figure 2). The presence of ISAba1 upstream of blaOXA−23 may
contribute to carbapenem resistance by increasing the expression
level of the gene by virtue of its outward-directed promoter (Zhu
et al., 2013). The Tn2006-like structure was inserted immediately
downstream from 1Tn6022 or Tn6022, and interestingly in
AC12-RI1 and AC29-RI1, the orf4 gene found at the right-most
end of 1Tn6022 was duplicated, resulting in the 1Tn2006-
like structure being flanked by orf4 on either end (Figure 2).
Such an arrangement has not been reported in similar resistance
islands before. Besides that, comparison between the Tn2006
present in the three RIs and Tn6167 showed some differences.
Tn6167 harbors Tn2006, but at a different location whereas both
RIMDR−TJ and AbaR22 do not contain Tn2006. However, the
right end of the islands were identical with Tn6167, RIMDR−TJ
and AbaR22 and comprises of tetA(B)-tetR(B), the small mobile
element CR2, strA-strB and orf4b, a hypothetical ORF related to
orf4 of Tn6022 and Tn602211 (Figure 2).
The structures of AC29-RI1 and AC30-RI1 indicated that
they are novel variants of the AbaR4-type RIs that were recently
reported in a survey of RIs found in A. baumannii strains
throughout Asia (Kim et al., 2013). Kim et al. (2013) also reported
that AbaR4-type RIs were commonly found among carbapenem-
resistant CC92 strains which included the ST195 lineage.
Plasmids of A. baumannii AC29 and AC30
A Small 8.7 kb Plasmid Found in Both AC29 and AC30
Plasmid pAC29a and pAC30a were almost identical to
pAC12 (Lean et al., 2015), pAB0057 (Adams et al., 2008),
p1ABTCDC0715 (Chen et al., 2011), and pPKAB07 (Saranathan
et al., 2014). A similar A. baumannii plasmid, pABVA01 (8963
bp), was found to harbor the blaOXA−24 carbapenese gene
flanked by XerC/XerD-like recombination sites (D’Andrea
et al., 2009) and this arrangement was also subsequently
reported in the 8771 bp plasmid pMMCU1 (Merino et al.,
2010). The XerC/XerD-like recombination sites were present
in pAC29a/pAC30a but with the selI gene instead of blaOXA−24
within the potential recombination region. The pAC12
plasmid from A. baumannii AC12 (Lean et al., 2015) and
pAB0057 from A. baumannii AB0057 (Adams et al., 2008) also
contained the sel1 gene in between the XerC/XerD sites. The
function of the sel1 gene is currently unknown. Other similar
Acinetobacter plasmids harbored different sized fragments
between the XerC/XerD recombination sites with p2ABAYE
from A. baumannii AYE (Fournier et al., 2006) for example,
harboring a putative alcohol dehydrogenase gene (Figure 3).
The blaOXA−24 gene is so far reported only in strains from Italy
and Spain (D’Andrea et al., 2009; Merino et al., 2010). This
was corroborated in a recent multicenter study which showed
that the blaOXA−24/blaOXA40−like genes in A. baumannii strains
isolated from Spain was predominantly carried by small 8–12 kb
plasmids with two of the sequenced plasmids, pAbATCC223
and pAbATCC329, harboring the blaOXA−24 gene in between
the XerC/XerD sites (Mosqueda et al., 2013). Xer recombination
is a site-specific recombination mechanism involved in events
such as the integration of phage CTX-8 at the dif1 site in the
Vibrio cholerae chromosome (D’Andrea et al., 2009). Moreover,
the proteins required for Xer recombination, such as the XerC
and XerD recombinases and PepA are reportedly encoded in
the chromosome of several A. baumannii strains (Merino et al.,
2010). Thus, the XerC/XerD-like sites on these 8.7 kb plasmids
could act as site-specific recombination targets responsible for
mobilization of discrete gene modules such as blaOXA−24 and sel1
within Acinetobacter plasmids (D’Andrea et al., 2009; Merino
et al., 2010).
Other highlights of this small plasmid are the presence of a
toxin-antitoxin (TA) system designated AbkB/AbkA (Mosqueda
et al., 2014) and a gene encoding a possible TonB-dependent
receptor protein. Most TA systems are usually characterized by
two co-transcribed genes with the antitoxin gene preceding the
toxin gene (Chan et al., 2012; Hayes and Kêdzierska, 2014).
AbkB/AbkA seems to differ from canonical TA systems as the
abkB toxin gene precedes the abkA antitoxin gene. To date, only
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three characterized TA loci have been reported to display this
unusual genetic arrangement: the mqsRA (Brown et al., 2009),
the higBA (Tian et al., 1996), and hicAB (Jørgensen et al., 2009)
modules. AbkB/AbkA was previously identified as one of the
four functional TA systems in A. baumannii (it was designated
SplT/SplA or DUF497/COG3914) whereby overexpression of
the toxin was shown to inhibit growth in E. coli and this was
overcame by co-expression of the cognate antitoxin (Jurenaite
et al., 2013). The AbkB (or SplT) toxin was shown to inhibit
translation when overexpressed in E. coli with cleavage of lpp
mRNA and transfer-messenger RNA (tmRNA) demonstrated,
thus indicating that the AbkB toxin likely functions as an
endoribonuclease or RNA interferase. The AbkB/AbkA locus was
found to be highly prevalent in small plasmids of A. baumannii
clinical strains (88.6% prevalence among 476 clinical isolates
from Lithuania; Jurenaite et al., 2013). The presence of a TA
system on these plasmids would explain their stability in the
absence of any apparent selection pressure, particularly for the
small plasmids without the blaOXA−24/blaOXA40−like gene such as
pAC30a and pAC29a.
Some TonB-dependent receptors, in particular BauA, play
important roles in the acquisition of iron in A. baumannii
(Dorsey et al., 2004; Mihara et al., 2004) with recent
transcriptomic and proteomic analyses indicating approximately
20 TonB-dependent receptors in A. baumannii, some of which
are regulated by iron (Antunes et al., 2011; Eijkelkamp et al.,
2011; Nwugo et al., 2011). TonB-dependent receptors are usually
found in the outer membrane where they interact with TonB
and associated inner membrane proteins (ExbB and ExbD) that
provide energy needed to transport host iron-carrier and iron-
siderophore complexes into the periplasm once these complexes
are bound to the TonB-dependent receptors (Zimbler et al.,
2013). Thus, along with TonB, the TonB-depended receptors play
an important role in the virulence of A. baumannii. Whether
the TonB-dependent receptor protein encoded by these small
plasmids plays a similar role in iron acquisition and hence,
virulence, awaits further experimentation. Another possible
virulence-associated gene encoded in these small plasmids is
found downstream of the gene encoding the TonB-dependent
receptor. This gene is predicted to encode a 152-amino acids-
residue protein homologous to septicolysin, a putative virulence
factor (Mosqueda et al., 2014). Septicolysin is a member of
thiol-activated cytolysins which have been implicated in the
pathogenesis of infections by several Gram-positive pathogens
such as Clostridium perfringens, Listeria monocytogenes, and
Streptococcus pneumoniae and are characterized by their cytolytic
activity for eukaryotic cells (Billington et al., 2000). With two
putative virulence factors encoded on these small plasmids, it
would therefore be of interest to investigate if these plasmids
play a role in the virulence and pathogenesis of A. baumannii
infections, especially in view of their prevalence among clinical
A. baumannii isolates.
pAC30b, a 16.2 kb Resistance Plasmid Found in A.
baumannii AC30
Both pAC30b and pMDR-ZJ06 are resistance plasmids, as
indicated by the presence of genes which confer resistance to
aminoglycosides and macrolides within the 7 kb Tn1548::armA
resistance island (Zhou et al., 2011). Interestingly, Tn1548::armA
is located in the chromosome of A. baumannii AC12 (Lean
et al., 2015) as well as in A. baumannii AC29. In both cases,
Tn1548::armA was found downstream of a cluster of five genes
encoding proteins annotated as paraquat-inducible protein A
and protein B. The pMDR-ZJ06 plasmid harbors a class 1
integron encoding the aminoglycoside acetyltransferase (aacC1)
and adenyltransferase (aadA1) along with sulI that confers
sulphonamide resistance (Zhou et al., 2011) but this integron was
absent in pAC30b.
Besides pMDR-ZJ06, pAC30b also shared sequence
identity with p3BJAB0868 from A. baumannii BJAB0868
and p2BJAB07104 from A. baumannii BJAB07104 (Zhu et al.,
2013) and this is mainly an approximately 10 kb fragment that
spanned Tn1548::armA, IS66 and the rep gene. Two other parts
of pAC30b that were identical with pMDR-ZJ06, p3BJAB0868,
and p2BJAB07104 are IS26 and the aphA1 gene, both of which
were in different locations in pAC30b when compared with
pMDR-ZJ06 (Figure 4), p3BJAB0868, and p2BJAB07104. The
aphA1 gene is flanked by two copies of IS26 in a composite
transposon-like structure designated Tn6210 in p3BJAB0868
and p2BJAB07104 (Zhu et al., 2013) as well as pMDR-ZJ06 but
in pAC30b, only one copy of IS26 is found adjacent to aphA1.
It is possible that a deletion had occurred in pAC30b that took
out the other copy of IS26 as well as part of the tnpU gene
of Tn1548::armA which is located adjacent to the IS26-aphA1
structure. All three plasmids pMDR-ZJ06, p3BJAB0868, and
p2BJAB07104 which were isolated from A. baumannii strains
in China, harbored a class 1 integron but this was absent in
pAC30b.
It is noteworthy that in contrast to pAC30a and pAC29a,
pAC30b has very few similar plasmids in other A. baumannii
isolates besides pMDR-ZJ06, p3BJAB0868, and p2BJAB07104,
suggesting that these plasmids are not so prevalent. What the
four A. baumannii plasmids (namely, pAC30b, pMDR-ZJ06,
p3BJAB0868, and p2BJAB07104) have in common are (1) a
number of transposases encoded by IS elements and transposons,
and (2) a lack of any plasmid stability genes such as toxin-
antitoxin systems. Thus, there is a likelihood that these plasmids
are much less stable as compared to the smaller pAC29a/pAC30a
plasmid which is endowed with the AbkB/AbkA toxin-antitoxin
system. Hence, in A. baumannii AC29 (and AC12), portions of
pAC30b are chromosomally-located and there is no widespread
occurrence of pAC30b-like plasmids in other A. baumannii
strains.
A Large ca. 70 kb Conjugative Plasmid in the
Genomes of A. baumannii AC29 and AC30
The tra locus in pAC29b and pAC30c encodes for a type
IV secretion system (T4SS) which is related to the bacterial
conjugation machinery and mediates horizontal gene transfer
(Juhas et al., 2008). Plasmids pAb-G7-2, pA85-3, and even
pACICU2 have been demonstrated to be transmissible by
conjugation to other A. baumannii strains (Hamidian and Hall,
2014; Hamidian et al., 2014). It is thus very likely that pAC29b
and pCA30c are also conjugative as the tra locus in these
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plasmids is almost identical. In pAb-G7-2, the space between
these two regions contained the aminoglycoside resistance
transposon, TnaphA6 (Hamidian and Hall, 2014) whereas in
pA85-3, the AbaR4 resistance island is located in the same
area (Hamidian et al., 2014). In pAC30c, this region contained
several hypothetical ORFs and a solitary relE toxin gene without
the corresponding relB antitoxin gene. However, the two genes
flanking relE could perhaps function as the antitoxin as they
encode for hypothetical proteins of about the same size as the
putative RelE toxin. Toxin-antitoxin pairs are usually about the
same size with a few exceptions such as the Zeta toxin which is
much larger (∼270 amino acids) as compared to their cognate
Epsilon antitoxin (∼90 amino acids; Chan et al., 2012; Jurenaite
et al., 2013). Although toxins usually interact with their cognate
antitoxin pair, sometimesmixing andmatching between different
toxin and antitoxin families do occur (Chan et al., 2012; Hayes
and Kêdzierska, 2014). Nevertheless, the functionality of the
plasmid pAC30c and pAC29b-encoded relE toxin gene needs to
be ascertained.
Both pAC30c and pAC29b carry the rep gene designated
repAci6, similar to pACICU2, pAb-G7-2, and pA85-3.
Another solitary toxin, this time from the Zeta family, is
located downstream from the repAci6 gene in both plasmids.
Experimental evidence had suggested that its overexpression is
non-toxic to E. coli and thus, may not function as a typical toxin
(Jurenaite et al., 2013). Its putative antitoxin partner, located
upstream of its reading frame, does not bear any homology
to the Epsilon antitoxin. These solitary Zeta-like toxins have
been observed in several other plasmids in diverse bacterial
species and their function is currently unknown (Chan et al.,
2012; Jurenaite et al., 2013). In the absence of typical canonical
toxin-antitoxin systems, the only other identifiable genes that
could contribute to plasmid stability in pAC30c and pAC29b are
the parAB genes which likely encode proteins that are involved
in plasmid partitioning.
Plasmid pAC29b harbors a blaOXA−23 gene but unlike the
A. baumannii A85 plasmid pA85-3 (Hamidian et al., 2014), the
gene is not located within an AbaR4 island. Both pAb-G7-2
and pACICU2 harbor the aminoglycoside resistance gene aphA6
within a composite transposon designated TnaphA6 (Hamidian
and Hall, 2014; Hamidian et al., 2014). Plasmid pAC30c however,
does not encode any known resistance determinant.
Investigations into the Possible
Contributors of Polymyxin Resistance in A.
baumannii AC30
The mechanism for polymyxin resistance in A. baumannii
has only recently been elucidated and the main mechanism
appeared to be either covalent modification of the lipid A
portion of LPS (Arroyo et al., 2011; Beceiro et al., 2011) or
disruption of LPS biosynthesis (Moffatt et al., 2010; Park et al.,
2011). By modification and/or mutations in the amino acid
sequences, negative charges on the outer membrane can be
reduced, leading to reduction in the affinity of the positively-
charged polymyxin component, hence giving rise to polymyxin
resistance (Adams et al., 2009; Arroyo et al., 2011; Beceiro
et al., 2011). Overexpression of the two-component signal
transduction system pmrAB and mutations within these genes,
especially pmrB, were reported to contribute to polymyxin
resistance (Adams et al., 2009; Arroyo et al., 2011; Park et al.,
2011). These two genes are part of an operon along with
pmrC, which encodes the enzyme responsible for the covalent
addition of phosphoethanolamine to lipid A. Sequence analysis
of pmrCAB from the polymyxin-resistant AC30 in comparison
with the polymyxin-susceptible AC29 and other susceptible
strains in the database (including ATCC19606 and ATCC17978)
showed a P102H mutation within pmrA. Identical mutations
were found within pmrA of AC12 (Lean et al., 2015) and
other polymyxin-resistant isolates from Terengganu (Lean et al.,
2014). Polymyxin-resistant isolate AC12 displayed higher pmrA
expression levels (8.5-folds) and also higher pmrB levels (about
two-folds) in comparison with ATCC19606. In contrast, the
polymyxin-susceptible AC29 isolate showed dramatically lower
pmrAB expression (0.05- and 0.03 folds). It should be noted that
in this case, no isogenic polymyxin-susceptible strains for the
polymyxin-resistant strains were available for comparison. Thus,
the expression levels for AC29, AC30, and AC12 were compared
with the non-isogenic reference strain ATCC19606 and therefore
may not yield an accurate picture for the pmrAB levels.
Nevertheless, the results do indicate upregulation particularly for
pmrB in both the polymyxin-resistant isolates AC30 and AC12.
The lpxA, lpxC, and lpxD genes encode the first three enzymes
in the lipid A biosynthesis pathway (Moffatt et al., 2010, 2011).
No mutation was found in lpxA. In contrast, lpxD showed
three amino acid mutations (S102T, V141I, R173G) in AC30
while lpxC had a K141R substitution. The lpsB gene encodes a
glycosyltransferase is involved in the biosynthesis of the LPS core
and was recently implicated in A. baumannii colistin resistance
(Hood et al., 2013). Comparison of lpsB sequences indicated a
H181Y substitution in AC30. Identical mutations in lpxD, lpxC,
and lpsB were reported in the polymyxin-resistant A. baumannii
AC12 (Lean et al., 2015); likewise, these and other mutations
had been previously reported in the polymyxin-resistant A.
baumannii strains from Terengganu (Lean et al., 2014). Results
from the LPS analysis indicated that the LPS in the polymyxin
resistant strains AC12 and AC30 were considerably less when
compared with the LPS band of the polymyxin-susceptible
strains, which has been previously reported in other polymyxin-
resistant strains (Moffatt et al., 2010, 2011; Hood et al., 2013).
This suggested that the mutations found in the lpxD, lpxC, and
lpsB genes in the two polymyxin-resistant strains may have led
to impairment but not a total loss of the LPS. It is likely that
in the case of AC12 and AC30, polymyxin resistance could
be the result of a combination of increased pmrAB expression
leading to covalent modification of the lipid A moiety of LPS
and possibly impaired LPS synthesis as well. Nevertheless, it
should be noted that in a recent study (Hood et al., 2013),
screening of transposon mutant libraries led to the identification
of more than 20 genes that may be involved in inducible colistin
resistance in A. baumannii. Most of these genes converged on
pathways involved in osmotolerance, cell envelope biosynthesis
along with protein folding (Hood et al., 2013). The role that these
factors may play in the development of polymyxin resistance
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in the Terengganu A. baumannii strains would also need to be
investigated.
AmpC-Mediated Resistance to
Extended-Spectrum Cephalosporins
Resistance to β-lactam antibiotics via synthesis of β-lactamase
encoded by the chromosome and/or plasmids is the most
common resistance mechanism observed in A. baumannii
(Bou and Martínez-Beltrán, 2000). Resistance to broad-
spectrum cephalosporins in A. baumannii are usually related
to the over production of extended spectrum β-lactamases
(ESBL), especially AmpC-type β-lactamases designated ADCs
(Acinetobacter-derived cephalosporinases) (Rodríguez-Martínez
et al., 2010). ADCs typically hydrolyze penicillins, narrow-
and extended-spectrum cephalosporins but not zwitterionic
cephalosporins such as cefepime or carbapenems (Rodríguez-
Martínez et al., 2010). However, extended-spectrum AmpCs
(ESACs) have been reported inA. baumannii that confer reduced
susceptibility to all cephalosporins and this includes ADC-33
(Rodríguez-Martínez et al., 2010) and ADC-56 (Tian et al.,
2011).
Since the recombinant E. coli BL21 carrying the blaAmpC from
AC29 and AC30 displayed resistance to ceftazidime, cefepime,
aztreonam, and even imipenem, this strongly suggests that the
AmpC from AC29 and AC30 is an ESAC cephalosphorinase.
ADC-33 possessed a P210R substitution together with a
duplication of the Ala residue at position 215 within the 
loop, both of which are required for extended spectrum activity
(Rodríguez-Martínez et al., 2010). ADC-56 possesed an R148Q
mutation also within the  loop, that enabled the enzyme to
hydrolyze cefepime (Tian et al., 2011). Thus, the G246S mutation
within the  loop of the AmpC from AC29 and AC30 could
be responsible for the extended spectrum activity. This could
be examined and verified by site-directed mutagenesis of the
pET30a recombinant clones. Likewise, the contribution of the
R80S mutation toward extended spectrum activity should be
investigated even though it is located in a non-active site.
CONCLUSIONS
In this study, we presented the comparative genome analyses
of two Malaysian A. baumannii strains AC29 and AC30
that belonged to the ST195 lineage and had identical ApaI
pulsotype but different susceptibilities to polymyxin. Their
MLST profiles and phylogenetic clustering based on their
concatenated MLST sequences clearly showed these strains
belonging to the International Clone II (IC-II) group. Novel
resistance island (RI) variants and plasmids were discovered
from the genome sequence of these strains. Both strains shared
a similar AbaR4-type RI of approximately 22 kb interrupting
the comM gene insertional hotspot and which contains the
carbapenem resistance gene, blaOXA−23 within a composite
transposon, Tn2006. The island also encodes genes conferring
resistance to tetracyclines, sulphonomides and streptomycin.
Both A. baumannii strains harbored a small ∼8 kb cryptic
plasmid which encode putative virulence determinants (TonB-
dependent receptor and septicolysin) as well as a XerC/XerD
recombination site. Plasmid pAC30b is found only in AC30 but
not AC29 and contained the Tn1548::armA island that confers
resistance to aminoglycosides and macrolides. Interestingly, this
island was found in the chromosome of AC29. Both AC30 and
AC29 harbored a∼70 kb conjugative plasmid designated pAC30c
and pAC29b with pAC29b containing a copy of blaOXA−23.
Thus, genomic islands and, to a lesser extent, conjugative
plasmids, appeared to play an important role in the dissemination
and acquisition of antibiotic resistance determinants in the
Terengganu A. baumannii strains. Experimental evidence also
indicated that polymyxin resistance in AC30may have developed
through a combination of pmrAB upregulation and partial
impairment of the lipopolysaccharide layer. The blaAmpC variant
encoded by both AC29 and AC30 was also shown to be likely
an extended-spectrum Acinetobacter-derived AmpC (ESAC)
conferring resistance to cefepime as well as imipenem. Whole
genome sequencing of the two Terengganu A. baumannii
clinical strains and subsequent experiments enabled a detailed
characterization of their genetic repertoire of resistance, thereby
giving us an insight into the genetic blueprint of Malaysian
isolates of this increasingly important and deadly nosocomial
pathogen.
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